Among the cancer-associated proteins we found five hotspot mutations conferring loss (NFE2L2 E79V/Q) or gain (PMS2 R107W, MUTYH S321L, CTNNB1 S33F) of interactions (Fig. 6C; Dataset EV6). Here, NFE2L2 is linked to cancer.